期刊文献+

类风湿关节炎二线药物用药决策分析 被引量:3

Selection of second-line drugs in rheumatoid arthritis
下载PDF
导出
摘要 目的 通过回顾性研究比较不同二线药物治疗类风湿关节炎(RA)的副反应发生率和撤药率,为临床医生选择二线药物提供决策依据。方法 由经过训练的调查员调查864例RA病人以往服用过的二线药物,这些药物有无副反应和有何种副反应。结果 上腹不适为二线药物最常出现的副反应;甲氨蝶呤胃肠道副反应(发生率为 143.1/1 000人年)最多见;青霉胺和风痛宁突出表现为皮肤出现瘙痒性皮疹(分别为84.4和87.7/1 000人年)。雷公藤多甙最常见的副反应是月经周期的紊乱(54.1/1 000人年)。柳氮磺吡啶主要是胃肠道症状(上腹不适 118.9/1000人年,纳差59.4/1 000人年)。眼部不适、视力下降(157.6/1 000人年)是使用氯喹最常见的不适主诉。二线药物副反应程度是有差别的。药物副反应是引起各种二线药物撤药的主要原因,甲氨蝶呤撤药率最低。甲氨蝶呤和雷公藤多甙、风痛宁和青霉胺有相似的副反应模式。结论 熟悉二线药物副反应,有利于临床医师选择药物和治疗方案。注意监测和对症处理副反应,二线药物仍然是安全的。 Objective To evaluate the adverse effect rate and withdrawal rate for second-line drugs frequently used in the treatment of rheumatoid arthritis (RA) . Methods Eight hundred and sixty-four RA patients had been investigated in the retrospective study. Results Upper abdominal trouble was mostly associated with second-line drugs usage. Rash was the most common toxic event with D-penicillamine (incidence 84.4/1 000 persons year) and sinomenium therapy (87.7/1 000 persons year). Methotrexate (MTX) was uniquely characterized by gastrointestinal toxicity (143.12/1 000 persons year) and tripterygium glycosides (TG) (54. 196) by menstrual abnormality. Sulfasalazine users complained of the upper abdominal trouble (118.9/1 000 persons year) and anorexia (59.4/1 000 persons year). Patients taking hydxoxy-chloroquine complained of blurred vision (157.6/1 000 persons year) but no one went blind. Discontinuation was usually attributed to toxic events and the patients taking MTX had the lowest withdrawal rate. D-penicillamine and sinomenium had a closely similar pattern of toxicity, as did TG and MTX. Conclusion Knowing well the different toxicity patterns enables more appropriate selection of second-line agents for particular RA patients. It is necessary for us to routinely monitor and symptomatically treat any adverse reactions occurred.
出处 《中国药物与临床》 CAS 2001年第1期20-24,共5页 Chinese Remedies & Clinics
关键词 药物副反应 药物 撤药 甲氨蝶呤 类风湿关节炎 常见 青霉胺 主要原因 调查员 决策分析 Arthritis, rheumatoid Retrospective study Adverse effect
  • 相关文献

参考文献5

  • 1American College of Rheumatology and HOC Committee of Clinical Guidelines.Guideline for monitoring drug therapy in rheumatoid arthritis.Arthritis Rheum,1996,39(5):723-731
  • 2American College of Rheumatology and HOC Committee of Clinical Guidelines.Guideline for the management of rheumatoid arthritis.Arthritis Rheum,1996,39(5):713-721
  • 3Singh G,Fries JF,Williams CA,et al.Toxicity profiles of disease modifying anti-rheumatic drugs in rheumatoid arthritis.J Rheumatol,1991,18(2):188-194
  • 4Fries JF,Spitz PW,Williams CA,et al.A toxicity index for comparison of side effects among different drugs.Arthritis Rheum,1990,33(5):121-130
  • 5Felson DT,Anderson,JJ,Meenan RF.Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis.Arthritis Rheum,1992,35(2):1117-1125

同被引文献76

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部